Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Jotte, Robert; Cappuzzo, Federico; Vynnychenko, Ihor; Stroyakovskiy, Daniil; Rodriguez-Abreu, Delvys; Hussein, Maen; Soo, Ross; Conter, Henry J.; Kozuki, Toshiyuki; Huang, Kuan-Chieh; Graupner, Vilma; Sun, Shawn W.; Hoang, Tien; Jessop, Helen; McCleland, Mark; Ballinger, Marcus; Sandler, Alan; Socinski, Mark A.

authors

Publication Date

  • August 1, 2020

webpage

published in

category

keywords

  • Atezolizumab
  • Carboplatin
  • IMpower131
  • Nab-paclitaxel
  • Squamous NSCLC

start page

  • 1351

end page

  • 1360

volume

  • 15

issue

  • 8